Format

Send to

Choose Destination
BMC Nephrol. 2013 Jul 29;14:164. doi: 10.1186/1471-2369-14-164.

The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality.

Author information

1
Bioscience, CVMD iMED, AstraZeneca R&D Mölndal, Mölndal, Sweden. david.gustafsson@astrazeneca.com

Abstract

Uric acid is the end product of purine metabolism in humans. High levels are causative in gout and urolithiasis. Hyperuricaemia has also been implicated in the pathophysiology of hypertension, chronic kidney disease (CKD), congestive heart failure (CHF), the metabolic syndrome, type 2 diabetes mellitus (T2DM), and atherosclerosis, with or without cardiovascular events. This article briefly reviews uric acid metabolism and summarizes the current literature on hyperuricaemia in cardiovascular disease and related co-morbidities, and emerging treatment options.

PMID:
23895142
PMCID:
PMC3750299
DOI:
10.1186/1471-2369-14-164
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center